CSPC Pharmaceutical Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SHSC:1093 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Dec 24	BuyHK$4,797,996	Dongchen Cai	Individual	1,000,000	HK$4.80
13 Dec 24	BuyHK$4,797,996	Dongchen Cai	Individual	1,000,000	HK$4.80
27 Nov 24	BuyHK$2,451,025	Dongchen Cai	Individual	484,000	HK$5.06
26 Nov 24	BuyHK$2,032,001	Dongchen Cai	Individual	400,000	HK$5.08
25 Nov 24	BuyHK$5,082,000	Dongchen Cai	Individual	1,000,000	HK$5.08
22 Nov 24	BuyHK$5,150,001	Dongchen Cai	Individual	1,000,000	HK$5.15
21 Nov 24	BuyHK$1,042,000	Dongchen Cai	Individual	200,000	HK$5.21
19 Nov 24	BuyHK$2,049,999	Dongchen Cai	Individual	400,000	HK$5.12
09 Sep 24	BuyHK$4,612,003	Dongchen Cai	Individual	1,000,000	HK$4.61
29 Aug 24	BuyHK$4,809,003	Dongchen Cai	Individual	1,000,000	HK$4.81
29 Aug 24	BuyHK$950,000	Hao Jiang	Individual	200,000	HK$4.75
28 Aug 24	BuyHK$8,050,009	Dongchen Cai	Individual	1,700,000	HK$4.74
28 Aug 24	SellHK$47,713,214	BlackRock, Inc.	Company	10,016,000	HK$4.76
26 Aug 24	BuyHK$3,827,041	Dongchen Cai	Individual	800,000	HK$4.78
23 Aug 24	BuyHK$5,691,956	Dongchen Cai	Individual	1,200,000	HK$4.74
22 Aug 24	BuyHK$6,722,301	Dongchen Cai	Individual	1,378,000	HK$4.88
22 Aug 24	BuyHK$4,892,798	Cuilong Zhang	Individual	1,000,000	HK$4.89
21 Mar 24	SellHK$42,259,404	UBS Asset Management AG	Company	6,584,000	HK$6.42

Insider Trading Volume

Insider Buying: 1093 insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1093?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	755,785,313	6.49%
Individual Insiders	2,843,505,350	24.4%
Institutions	3,724,577,517	32%
General Public	4,314,433,552	37.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 57.18% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
24.2%	Dongchen Cai	2,819,937,670	HK$13.5b	0.16%	no data
6.26%	Common Success International Limited	728,796,313	HK$3.5b	0%	no data
5.15%	UBS Asset Management AG	599,349,498	HK$2.9b	4.18%	0.04%
4.55%	BlackRock, Inc.	529,654,351	HK$2.5b	0.02%	0.01%
3.03%	The Vanguard Group, Inc.	353,046,338	HK$1.7b	0.48%	no data
2.17%	First Sentier Investors (Australia) IM Ltd	252,468,494	HK$1.2b	0%	0.45%
2%	Norges Bank Investment Management	232,933,324	HK$1.1b	0%	0.01%
1.24%	Bosera Asset Management Co., Ltd.	143,912,000	HK$688.4m	0%	0.39%
1.12%	State Street Global Advisors, Inc.	130,387,879	HK$623.7m	0.32%	no data
0.83%	Dimensional Fund Advisors LP	96,431,437	HK$461.2m	-4.15%	0.01%
0.73%	abrdn plc	85,336,722	HK$408.2m	0%	0.04%
0.7%	GF Fund Management Co., Ltd.	81,780,000	HK$391.2m	0%	0.1%
0.68%	China Asset Management Co. Ltd.	78,658,795	HK$376.2m	-0.29%	0.05%
0.61%	Harvest Fund Management Co. Ltd.	71,474,040	HK$341.9m	0%	0.09%
0.5%	Caisse de dépôt et placement du Québec	58,092,837	HK$277.9m	0%	0.03%
0.48%	Hang Seng Investment Management Limited	55,812,524	HK$267.0m	-0.38%	0.34%
0.46%	JP Morgan Asset Management	53,533,994	HK$256.1m	-3.07%	no data
0.34%	Geode Capital Management, LLC	39,453,980	HK$188.7m	1.23%	no data
0.33%	Zhong Ou Fund Management Co., Ltd	38,600,000	HK$184.6m	0%	0.09%
0.32%	Schroder Investment Management (Hong Kong) Ltd.	37,590,000	HK$179.8m	0%	0.13%
0.31%	Eastspring Investments (Singapore) Limited	36,642,800	HK$175.3m	0%	0.07%
0.31%	UBS SDIC Fund Management Co., Ltd.	35,566,640	HK$170.1m	0%	0.51%
0.28%	E Fund Management Co., Ltd.	32,668,295	HK$156.3m	0.03%	0.02%
0.27%	American Century Investment Management Inc	31,251,144	HK$149.5m	3.29%	0.01%
0.27%	Amundi Asset Management SAS	30,916,508	HK$147.9m	-0.65%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/24 13:47
End of Day Share Price	2024/12/24 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CSPC Pharmaceutical Group Limited is covered by 50 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Wai Chak Yuen	BOCI Research Ltd.
Sharon Shi	BOCI Research Ltd.
Ethan Cui	BofA Global Research